Can chemoimmunotherapy in CLL treatment be replaced with novel agents?
How to explain the 'watch-and-wait' period to a CLL patient?
Why do charities need to keep funding research into leukemia and blood cancer in general?
Lymphoma highlights from EHA 2016
Overview of research in Waldenström’s macroglobulinemia therapies